News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ferndale Laboratories, Inc. to Implement I-many (IMNY) Integrated Contract Lifecycle Management Solution


4/26/2007 1:55:25 PM

EDISON, N.J.--(BUSINESS WIRE)--I-many, Inc. (NASDAQ:IMNY), the leading provider of advanced Contract Lifecycle Management (CLM) solutions for managing corporate commitments, today announced that Ferndale Laboratories, a leading dermatological pharmaceuticals company delivering unique therapies that help heal, protect, and beautify the skin, has signed a five-year license agreement to implement I-many CARS and I-many Medicaid. I-many’s integrated approach to Contract Lifecycle Management will enable Ferndale to optimize rebates and chargebacks as their business grows and as regulatory requirements increase.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES